These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12459036)

  • 1. Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.
    Bulotta A; Hui H; Anastasi E; Bertolotto C; Boros LG; Di Mario U; Perfetti R
    J Mol Endocrinol; 2002 Dec; 29(3):347-60. PubMed ID: 12459036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells.
    Hui H; Wright C; Perfetti R
    Diabetes; 2001 Apr; 50(4):785-96. PubMed ID: 11289043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
    Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
    Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1.
    Doyle ME; Egan JM
    Recent Prog Horm Res; 2001; 56():377-99. PubMed ID: 11237222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells.
    Zhou J; Wang X; Pineyro MA; Egan JM
    Diabetes; 1999 Dec; 48(12):2358-66. PubMed ID: 10580424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLP-1 ameliorates the proliferation activity of INS-1 cells inhibited by intermittent high glucose concentrations through the regulation of cyclins.
    Zhang Z; Li J; Jiang X; Yang L; Lei L; Cai D; Zhang H; Chen H
    Mol Med Rep; 2014 Aug; 10(2):683-8. PubMed ID: 24859892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLP-1 stimulates glucose-derived de novo fatty acid synthesis and chain elongation during cell differentiation and insulin release.
    Bulotta A; Perfetti R; Hui H; Boros LG
    J Lipid Res; 2003 Aug; 44(8):1559-65. PubMed ID: 12777469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
    Farilla L; Bulotta A; Hirshberg B; Li Calzi S; Khoury N; Noushmehr H; Bertolotto C; Di Mario U; Harlan DM; Perfetti R
    Endocrinology; 2003 Dec; 144(12):5149-58. PubMed ID: 12960095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of stimulators such as GLP-1, PACAP, and nicotinamide on glucose-stimulated insulin secretion from porcine pancreatic endocrine cells in long-term culture.
    Sato A; Wang PC; Ohgawara H
    Pancreas; 2002 Jul; 25(1):86-93. PubMed ID: 12131777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
    Miura Y; Matsui H
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
    Lam NT; Kieffer TJ
    Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism.
    Wang X; Zhou J; Doyle ME; Egan JM
    Endocrinology; 2001 May; 142(5):1820-7. PubMed ID: 11316746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional maturation of fetal porcine beta-cells by glucagon-like peptide 1 and cholecystokinin.
    Hardikar AA; Wang XY; Williams LJ; Kwok J; Wong R; Yao M; Tuch BE
    Endocrinology; 2002 Sep; 143(9):3505-14. PubMed ID: 12193564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC; Bhatt HS; Easom RA
    Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of GLP-1 in the life and death of pancreatic beta cells.
    Perfetti R; Hui H
    Horm Metab Res; 2004; 36(11-12):804-10. PubMed ID: 15655712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-induced regulation of glucagon-like peptide-I receptor function and expression in insulin-secreting beta cells.
    Fehmann HC; Jiang J; Pitt D; Schweinfurth J; Göke B
    Pancreas; 1996 Oct; 13(3):273-82. PubMed ID: 8884849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells.
    Bai L; Meredith G; Tuch BE
    J Endocrinol; 2005 Aug; 186(2):343-52. PubMed ID: 16079260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-GLP-1: a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expression.
    Liu HK; Green BD; Gault VA; McCluskey JT; McClenaghan NH; O'Harte FP; Flatt PR
    Cell Biol Int; 2004; 28(1):69-73. PubMed ID: 14759771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.